|Day Low/High||82.02 / 82.86|
|52 Wk Low/High||60.32 / 82.33|
Recent company-related activities are worth noting and could merit action.
Nicole Urken, research associate of Jim Cramer, likes Abbott Labs and says it's not just an Obama trade.
Abbott gets some good news on its Hep C drug, which has buoyed Bristol-Myers. Some positive Hep C data out of Abbott Labs (ABT) (hat tip Steph Link!) is buyoing Bristol-Myers Squibb (BMY) this morning.
Here is this week's roundup of the dumbest actions on Wall Street.
Senior columnist Adam Feuerstein says hepatitis drugs are the next big thing to watch in biotech.
In this episode of Buy This, Sell That!, Robert Zagunis, portfolio manager for the Jensen Quality Growth fund, names his favorite stocks including Abbott Labs, UPS and Praxair.
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Amgen, Gilead, and Celgene.
Stephanie Link, director of research at TheStreet, eliminated her position in Abbott to build a position in Bristol Meyers.
Here's some of what we can look forward to on Wednesday. It's always an honor to fill in for Doug! Thanks for spending the day with me. Tomorrow, Fed Chairman Ben Bernanke appears before the House. His statement will likely be a replay of today's, b...
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Abbott Laboratories, ConocoPhillips, and Facebook.
Latch on to this rising trend with these names, which achieved top marks with my stock strategies.
Intel is attracting institutional buyers, and it always pays to follow that crowd.
I've finally picked up some Abbott Labs stock, which has been slowly breaking out of a base.
Oliver Pursche, portfolio manager for the GMG Defensive Beta fund, names his favorite high dividend paying stocks including McDonald's, Intel and Abbott Labs.
The pediatric nutrition company leads the industry, and demand remains firm despite economic slowdowns.